Erythrocyte antioxidant activity in human patients with Parkinson's disease

Neurosci Lett. 1987 Apr 10;75(3):345-8. doi: 10.1016/0304-3940(87)90547-7.

Abstract

Three groups have reported defective antioxidant mechanisms in substantia nigra of patients with Parkinson's disease, namely a decreased catalase and peroxidase activity, a reduction of glutathione and, more recently, a diminished nigral glutathione peroxidase activity. We decided to investigate these mechanisms in erythrocytes to determine whether these brain defects represent generalized or genetic aberrations, in which case they should also be present in blood cells. The glutathione cycle has been investigated (reduced and oxidized glutathione, glutathione reductase and peroxidase) plus the activities of catalase and superoxide dismutase. The basal malonaldehyde content of erythrocytes was used as an index of endogenous lipid peroxidation. None of the above-mentioned parameters were found altered in erythrocytes of parkinsonians, suggesting that no genetic or generalized biochemical abnormalities underly the deficiencies detected in substantia nigra.

MeSH terms

  • Erythrocytes / metabolism*
  • Glutathione / blood
  • Humans
  • Oxidation-Reduction
  • Parkinson Disease / blood*
  • Substantia Nigra / metabolism

Substances

  • Glutathione